17:42:35 EDT Mon 12 May 2025
Enter Symbol
or Name
USA
CA



News for C:CYBN from 2024-05-13 to 2025-05-12 - 39 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2025-05-08 17:29C:CYBNCybin Inc (2)11.80News ReleaseCybin receives U.S. Patent for its CYB003 program
2025-05-01 07:30C:CYBNCYBIN INC.11.80News ReleaseCybin to Participate at the 28th Annual Milken Institute Global Conference
2025-04-23 07:30C:CYBNCYBIN INC.11.80News ReleaseCybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003
2025-04-21 17:01C:CYBNCybin Inc (2)11.80News ReleaseCybin forms partnership with Osmind
2025-02-10 21:48C:CYBNCYBIN INC.13.25News ReleaseCybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
2025-02-10 20:55C:CYBNCybin Inc (2)13.25SEDAR Interim MD & ASEDAR Interim MD & A
2025-02-10 20:49C:CYBNCybin Inc (2)13.25SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-01-15 18:18C:CYBNCybin Inc (2)13.10News ReleaseCybin launches partnership agreement with Segal Trials
2025-01-13 20:59C:CYBNCybin Inc (2)12.56News ReleaseCybin summarizes 2024, looks ahead to 2025
2025-01-09 17:00C:CYBNCYBIN INC.13.85News ReleaseCybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
2024-12-10 17:21C:CYBNCybin Inc (2)14.45News ReleaseCybin presents two posters at ACNP in Arizona
2024-12-04 07:30C:CYBNCYBIN INC.14.85News ReleaseCybin to Participate in Water Tower Research Fireside Chat on December 11, 2024
2024-11-18 16:45C:CYBNCybin Inc (2)14.75News ReleaseCybin talks phase 2 efficacy data for CYB003
2024-11-14 07:30C:CYBNCYBIN INC.14.61News ReleaseCybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024
2024-11-14 07:12C:CYBNCybin Inc (2)15.42In the NewsGlobe says Cybin, Mind Medicine score U.S. FDA nod
2024-11-13 13:59C:CYBNCybin Inc (2)16.00News ReleaseCybin begins phase 3 program for CYB003
2024-11-13 07:34C:CYBNCybin Inc (2)16.00SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-11-13 07:34C:CYBNCybin Inc (2)16.00SEDAR Interim MD & ASEDAR Interim MD & A
2024-10-31 07:30C:CYBNCYBIN INC.13.62News ReleaseCybin to Participate at the 2024 Milken Institute Future of Health Summit
2024-10-24 14:19C:CYBNCybin Inc (2)News ReleaseCybin receives U.S. patent for CYB005 candidates
2024-10-03 07:30C:CYBNCYBIN INC.11.90News ReleaseCybin to Participate in Water Tower Research Fireside Chat on October 8, 2024
2024-10-01 15:17C:CYBNCybin Inc (2)12.00News ReleaseCybin appoints Rahman, Gutierrez as VPs
2024-09-24 07:30C:CYBNCYBIN INC.12.93News ReleaseCybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
2024-09-19 18:00C:CYBNCybin Inc (2)11.63News ReleaseCybin appoints Mahableshwarkar, Macek to lead programs
2024-09-19 09:24C:CYBNCybin Inc (2)0.265News ReleaseCybin completes 1:38 share rollback
2024-09-17 18:05C:CYBNCybin Inc0.27RollbackCybin 1:38 rollback
2024-08-27 19:16C:CYBNCybin Inc0.345News ReleaseCybin shareholders OK matters at AGM
2024-08-13 16:15C:CYBNCybin Inc0.36News ReleaseCybin holds FDA initial breakthrough therapy meeting
2024-08-08 17:54C:CYBNCybin Inc0.365News ReleaseCybin has June 30 cash position of $183-million
2024-08-08 07:36C:CYBNCybin Inc0.365SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-08-08 07:36C:CYBNCybin Inc0.365SEDAR Interim MD & ASEDAR Interim MD & A
2024-08-07 07:30C:CYBNCYBIN INC.0.355News ReleaseCybin to Participate in the Canaccord Genuity 44th Annual Growth Conference
2024-06-26 15:29C:CYBNCybin Inc0.34News ReleaseCybin ends fiscal 2024 with cash of $209-million
2024-06-26 07:40C:CYBNCybin Inc0.36SEDAR MD & ASEDAR MD & A
2024-06-26 07:33C:CYBNCybin Inc0.36SEDAR Annual Information FormSEDAR Annual Information Form
2024-06-26 07:33C:CYBNCybin Inc0.36SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-06-19 07:30C:CYBNCYBIN INC.0.365News ReleaseCybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
2024-06-11 10:54C:CYBNCybin Inc0.385News ReleaseCybin appoints Mahableshwarkar SVP, clinic development
2024-05-30 14:26C:CYBNCybin Inc0.465News ReleaseNuminus to host Cybin trial on CYB003 at Cedar Clinical